MAIER PAUL V
SEC Form 4 insider trading activity
MAIER PAUL V has filed 3 SEC Form 4 filings (10 transaction rows) across 2 companies, including ISCO, ETON, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 15, 2026.
On the most recent filing, MAIER PAUL V is listed as Director at International Stem Cell CORP. Inside the rolling window, MAIER PAUL V reported no open-market purchases and 2 open-market sales totaling $3.0M in ISCO and ETON. The largest disclosed transaction in the window is a sale of 50,000 ETON shares on Aug 28, 2026, worth $3.0M.
Companies traded
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.0M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has MAIER PAUL V made?
MAIER PAUL V has filed 3 SEC Form 4 filings (10 transaction rows) across 2 companies, including ISCO, ETON since 2026.
Which companies does MAIER PAUL V trade?
MAIER PAUL V has filed SEC Form 4 disclosures for 2 companies, including ISCO, ETON.
When was MAIER PAUL V's most recent SEC Form 4 filing?
MAIER PAUL V's most recent SEC Form 4 filing on Tracefour is dated Sep 15, 2026.
What is MAIER PAUL V's total buy and sell value in the current window?
Inside the rolling retention window, MAIER PAUL V bought $0 and sold $3.0M based on SEC Form 4 filings.
What was MAIER PAUL V's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 ETON shares on 2026-08-28, worth $3.0M, per SEC Form 4 filings.